Endocrine & Hormonal
Also called Chromaffin Cell Tumor, Paraganglioma (extra-adrenal)
Pheochromocytoma is a neuroendocrine tumor arising from chromaffin cells, most commonly in the adrenal medulla (90%), though extra-adrenal tumors (paragangliomas) occur in 10%. The tumor produces catecholamines (epinephrine and norepinephrine) that cause the characteristic symptoms.
Pheochromocytoma can develop at any age but is most common in the fourth and fifth decades of life. It affects males and females roughly equally. The disease occurs across all racial and ethnic groups. About 30-40% of cases are hereditary, associated with MEN2, NF1, VHL, or SDHA/B/C/D syndromes. Hereditary cases often present at younger ages and may be bilateral or extra-adrenal.
Clinical trials for Pheochromocytoma focus on novel targeted therapies for malignant and hereditary forms, including SDH inhibitors and other molecular approaches. Surgery is the primary treatment for localized disease, with trials optimizing perioperative management. Chemotherapy, radiation therapy, and molecular targeted therapies are being refined for malignant disease. Patients should consult with an endocrinologist experienced in adrenal tumors for appropriate genetic testing and treatment planning.
Addison Disease is a rare endocrine disorder in which the adrenal glands fail to produce adequate cortisol and aldostero...
Acromegaly is a rare hormonal disorder caused by excessive growth hormone production, typically from a pituitary adenoma...
Cushing Disease is a rare endocrine disorder caused by an ACTH-secreting pituitary adenoma that leads to excessive corti...